Gebretsadik, Heron Gezahegn
Article History
Received: 7 November 2022
Accepted: 21 July 2023
First Online: 7 August 2023
Declarations
:
: The authors declare no competing interests.
: The Addis Ababa Health Bureau Institutional Review Board (IRB) Ethics Committee approved this study. The approval number of the clearance statement is “A/A/H/B/2116/227.“ The medical information was kept confidential. In addition, the researcher used the patients’ initials in the questionnaire and excel sheet. Formal written informed consent was also obtained from the study participants.
: Not applicable.